693
Views
24
CrossRef citations to date
0
Altmetric
Drug Evaluations

Herpes simplex virus oncolytic vaccine therapy in melanoma

, MD, , , MD & , MD
Pages 1145-1153 | Published online: 01 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Elizabeth S Appleton, Samantha Turnbull, Christy Ralph, Emma West, Karen Scott, Kevin Harrington, Hardev Pandha & Alan Melcher. (2015) Talimogene laherparepvec in the treatment of melanoma. Expert Opinion on Biological Therapy 15:10, pages 1517-1530.
Read now
Donavon C Hiss & Burtram C Fielding. (2012) Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy. Expert Opinion on Biological Therapy 12:11, pages 1427-1447.
Read now

Articles from other publishers (22)

Robyn D. Gartrell, Zoë Blake, Emanuelle M. Rizk, Rolando Perez-Lorenzo, Stuart P. Weisberg, Ines Simoes, Camden Esancy, Yichun Fu, Danielle R. Davari, Luke Barker, Grace Finkel, Manas Mondal, Hanna E. Minns, Samuel W. Wang, Benjamin T. Fullerton, Francisco Lozano, Codruta Chiuzan, Basil Horst & Yvonne M. Saenger. (2022) Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma. Cancer Immunology, Immunotherapy 71:8, pages 1837-1849.
Crossref
Xin Xie, Jingwen Lv, Wei Zhu, Chao Tian, Jingfeng Li, Jiajia Liu, Hua Zhou, Chunyang Sun, Zongfeng Hu & Xiaopeng Li. (2022) The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy. Translational Oncology 15:1, pages 101287.
Crossref
Ravi N. Samy, Brian R. EarlNoga Lipschitz, Ivy SchweinzgerMark CurrierTimothy Cripe. (2019) Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study. Laryngoscope Investigative Otolaryngology 4:5, pages 532-542.
Crossref
Victoria A. Jennings, Gina B. Scott, Ailsa M.S. Rose, Karen J. Scott, Gemma Migneco, Brian Keller, Katrina Reilly, Oliver Donnelly, Howard Peach, Donald Dewar, Kevin J. Harrington, Hardev Pandha, Adel Samson, Richard G. Vile, Alan A. Melcher & Fiona Errington-Mais. (2019) Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition. Molecular Therapy 27:6, pages 1139-1152.
Crossref
Duaa O. Khair, Heather J. Bax, Silvia Mele, Silvia Crescioli, Giulia Pellizzari, Atousa Khiabany, Mano Nakamura, Robert J. Harris, Elise French, Ricarda M. Hoffmann, Iwan P. Williams, Anthony Cheung, Benjamin Thair, Charlie T. Beales, Emma Touizer, Adrian W. Signell, Nahrin L. Tasnova, James F. Spicer, Debra H. Josephs, Jenny L. Geh, Alastair MacKenzie Ross, Ciaran Healy, Sophie Papa, Katie E. Lacy & Sophia N. Karagiannis. (2019) Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma. Frontiers in Immunology 10.
Crossref
Valerio Leoni, Andrea Vannini, Valentina Gatta, Julie Rambaldi, Mara Sanapo, Catia Barboni, Anna Zaghini, Patrizia Nanni, Pier-Luigi Lollini, Costanza Casiraghi & Gabriella Campadelli-Fiume. (2018) A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors. PLOS Pathogens 14:8, pages e1007209.
Crossref
Matthew Marr, Anthony D’AbramoJr.Jr., Nikea Pittman, Mavis Agbandje-McKenna, Susan Cotmore & Peter Tattersall. (2018) Optimizing the Targeting of Mouse Parvovirus 1 to Murine Melanoma Selects for Recombinant Genomes and Novel Mutations in the Viral Capsid Gene. Viruses 10:2, pages 54.
Crossref
Arthur Dyer, Ying Di, Hugo Calderon, Sam Illingworth, Gray Kueberuwa, Alison Tedcastle, Phil Jakeman, Suet Lin Chia, Alice Brown, Michael A. Silva, David Barlow, John Beadle, Terry Hermiston, David J.P. Ferguson, Brian Champion, Kerry D. Fisher & Leonard W. Seymour. (2017) Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators. Molecular Therapy - Oncolytics 4, pages 18-30.
Crossref
Haruko Tashiro & Malcolm Brenner. 2016. Holland-Frei Cancer Medicine. Holland-Frei Cancer Medicine 1 7 .
Tanja Meyer Tamguney, W. Michael Korn & Frank McCormick. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer 753 768.e3 .
S Gholami, C-H Chen, S Gao, E Lou, S Fujisawa, J Carson, J E Nnoli, T-C Chou, J Bromberg & Y Fong. (2014) Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer. Cancer Gene Therapy 21:7, pages 283-289.
Crossref
Howard L. KaufmanDae Won KimSeunghee Kim-SchulzeGail DeRaffeleMichael C. JagodaJoseph R. BroucekAndrew Zloza. (2014) Results of a Randomized Phase I Gene Therapy Clinical Trial of Nononcolytic Fowlpox Viruses Encoding T Cell Costimulatory Molecules. Human Gene Therapy 25:5, pages 452-460.
Crossref
Samuel T Workenhe & Karen L Mossman. (2014) Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies. Molecular Therapy 22:2, pages 251-256.
Crossref
Andrew P. Byrnes, Ying Huang & Kevin Shannon. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer 503 515 .
Elham Mohit & Sima Rafati. (2013) Biological delivery approaches for gene therapy: Strategies to potentiate efficacy and enhance specificity. Molecular Immunology 56:4, pages 599-611.
Crossref
Yashin A. Mahamodhossen, Wei Liu & Zhou Rong-Rong. (2013) Triple-negative breast cancer: new perspectives for novel therapies. Medical Oncology 30:3.
Crossref
Yu-Ping Liu, Lukkana Suksanpaisan, Michael B. Steele, Stephen J. Russell & Kah-Whye Peng. (2013) Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy. Scientific Reports 3:1.
Crossref
Can Xu, Haihang Li, Changqing Su & Zhaoshen Li. (2013) Viral therapy for pancreatic cancer: Tackle the bad guys with poison. Cancer Letters 333:1, pages 1-8.
Crossref
John C. Bell. (2012) The Virus That Came In from the Cold. Science Translational Medicine 4:138.
Crossref
Rebecca AuerJohn C Bell. (2012) Oncolytic viruses: smart therapeutics for smart cancers. Future Oncology 8:1, pages 1-4.
Crossref
Vernon K. Sondak, Dale Han, Jeremiah Deneve & Ragini Kudchadkar. (2011) Current and planned multicenter trials for patients with primary or metastatic melanoma. Journal of Surgical Oncology 104:4, pages 430-437.
Crossref
Shanthi Sivendran, Bradley Glodny, Michael Pan, Miriam Merad & Yvonne Saenger. (2010) Melanoma Immunotherapy. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77:6, pages 620-642.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.